DNA Link will bring the power of the largest proteomics platform available to their biomarker discovery and drug development work BOULDER, Colo. and SEOUL, Korea, Sept. 19, 2023 (GLOBE NEWSWIRE) -- SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its

SomaLogic’s SomaScan® platform was used to target 15 markers shared among all cancer types. BOULDER, Colo., Sept. 12, 2023 (GLOBE NEWSWIRE) -- In a new paper published in Nature's Scientific Reports , researchers at SomaLogic Inc. studied the value of protein biomarkers in the early detection of

Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseases BOULDER, Colo., Sept. 05, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, announced today that it is extending its collaborative

Revenue of $20.5 million, an increase of 45% year-over-year Cash and investments of approximately $474 million, a strong capital position to fund current and future business initiatives Reiterating full year 2023 revenue guidance and operating expense target Management to host conference call today

BOULDER, Colo., July 24, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the second quarter 2023 after market close on August 14 th , 2023. Management will host a corresponding conference call beginning at 4:30

SomaLogic’s 7,000-plex SomaScan® Platform will be used in proteomics testing at scale in Europe BOULDER, Colo. and L’AQUILA, Italy, July 24, 2023 (GLOBE NEWSWIRE) -- SomaLogic Operating Co. Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership with

International designation signifies recognized standard for quality, reliability and competence in medical labs BOULDER, Colo. (June 21, 2023) — SomaLogic, Inc., a leader in proteomics technology, announced today that the company received the ISO 15189 accreditation, achieving all the requirements

SomaLogic’s 7,000-plex SomaScan® Platform will be used in clinical research, population health studies and nutrigenomics. BOULDER, Colo., June 12, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, announced today their collaboration with Citogen, the Longwood Group’s

Appoints Eliot M. Lurier, CPA, as Interim Chief Financial Officer Reaffirms 2023 Financial Guidance BOULDER, Colo., June 06, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc. (Nasdaq: SLGC), a leader in proteomics technology, today announced a Chief Financial Officer transition. Eliot M.

BOULDER, Colo., May 24, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that the company will be participating in the upcoming Jefferies Healthcare Conference. SomaLogic management is scheduled to participate in a fireside chat on Wednesday, June 7,